0001104659-21-008998.txt : 20210128 0001104659-21-008998.hdr.sgml : 20210128 20210128215700 ACCESSION NUMBER: 0001104659-21-008998 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210126 FILED AS OF DATE: 20210128 DATE AS OF CHANGE: 20210128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Granfield Christine CENTRAL INDEX KEY: 0001822190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37990 FILM NUMBER: 21567839 MAIL ADDRESS: STREET 1: C/O LEAP THERAPEUTICS STREET 2: 47 THORNDIKE STREET, SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274412575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 252 4343 MAIL ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Dekkun Corp DATE OF NAME CHANGE: 20110107 4 1 tm214605-6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-01-26 0 0001509745 LEAP THERAPEUTICS, INC. LPTX 0001822190 Granfield Christine C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1-1 CAMBRIDGE MA 02141 0 1 0 0 VP, Head of Reg Affairs/Qual Employee Stock Option (Right to Buy) 2.57 2021-01-26 4 A 0 50000 0 A 2031-01-25 Common Stock 50000 50000 D The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of January 26, 2021, the Vesting Start Date. /s/ Douglas E. Onsi, as attorney-in-fact for Christine Granfield 2021-01-28